Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

43.07
-0.9400-2.14%
Post-market: 43.110.0400+0.09%19:59 EDT
Volume:11.03M
Turnover:474.48M
Market Cap:192.31B
PE:10.76
High:43.50
Open:43.20
Low:42.72
Close:44.01
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.35
T/O Rate:0.35%
Dividend:1.72
Dividend Rate:4.00%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.91
PE(LYR):11.90

Loading ...

European Stocks Stalled Near Records as HSBC and Novo Nordisk Weigh

Deep News
·
Aug 06

Money Quote: Novo Nordisk CEO

Dow Jones
·
Aug 06

How Ozempic Maker Novo Nordisk Blew Its Lead in GLP-1 Weight-Loss Drugs. Can Europe Compete in the High-Stakes Global Economy?

Dow Jones
·
Aug 06

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Aug 06

Novo Nordisk Stock (NVO) Recovers as Earnings Surprise to the Upside

TIPRANKS
·
Aug 05

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Novo Nordisk Wins Dutch Injunction in Ceban Semaglutide Patent Case

MT Newswires Live
·
Aug 05

Movement Alert|Novo-Nordisk A/S Rises 3.11% in Regular Trading, Q2 Earnings Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Aug 05

Novo Nordisk CEO Remains Open to Bolt-on Acquisitions, but Rules Out Transformative Deals

Dow Jones
·
Aug 05

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Bloomberg
·
Aug 05

UBS Keeps Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
Aug 05

Novo-Nordisk CEO Defends Wegovy Oral Pill Amid Pricing Pressure, Shares Slide on Sales Concern

Deep News
·
Aug 05

Movement Alert|Novo-Nordisk A/S Pre-Market Rise 5.04%, Q2 Earnings Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Aug 05

European Stocks Extend Record Highs

Dow Jones
·
Aug 05

Movement Alert|Novo-Nordisk A/S Rises 3.14% Overnight, Q2 Earnings Beat Expectations as Management Signals Confidence in GLP-1 Growth

Market Focus
·
Aug 05

Novo Nordisk Shares Likely to Fall at Open, but Less than in U.S. Session

Dow Jones
·
Aug 05

Novo Nordisk A/S Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Novo Nordisk Earnings Beat but Study Data, Wegovy Pill Sales Underwhelm

Dow Jones
·
Aug 05

Dow Jones Top Company Headlines at 7 PM ET: SpaceX Revenue Could Reach $1 Trillion, Elon Musk Says | Paramount's ...

Dow Jones
·
Aug 05

Novo Nordisk Q2 Adj. EPS $0.96 Beats $0.81 Estimate, Sales $12.209B Beat $11.350B Estimate

Benzinga Earnings
·
Aug 05